Tag Archives: Drug

Winners And Losers Under Bold Trump Plan To Slash Drug Rebate Deals

Use Our Content This story can be republished for free (details). Few consumers have heard of the secret, business-to-business payments that the Trump administration wants to ban in an attempt to control drug costs. But the administration’s plan for drug rebates, announced Thursday, would end the pharmaceutical business as usual, shift billions in revenue and… Read More »

FDA declines to approve Alkermes opioid-based depression drug

(Reuters) – The U.S. Food and Drug Administration on Friday declined to approve Alkermes Plc’s opioid-based depression treatment, citing the need for additional data to prove the effectiveness of the drug. The largely expected decision comes months after an advisory panel to the FDA strongly voted against the drug and raised questions on its safety… Read More »

Teva's migrane drug gets EU panel nod

FILE PHOTO: The headquarters of the European Medicines Agency (EMA), is seen in London, Britain, April 25, 2017. REUTERS/Hannah McKay/File Photo (Reuters) – Teva Pharmaceutical Industries said a European Medicines Agency (EMA) panel on Friday recommended approving migraine treatment Ajovy, a drug that the company has been counting on to revive its fortune. Ajovy was… Read More »